New test provided through Infinity BiologiX (IBX) laboratories, powered by Cytox’s genoSCORE polygenic risk score platform, with Vanguard providing medical liaison and customer support available from ...
SAN DIEGO, July 31, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the market launch of its proprietary new generation monitoring ...
On January 17 2009, the regulations of Legislative Decree No 1072 regarding the "Pharmaceutical Test Data Protection and other undisclosed data of pharmaceutical products" were published in the ...
Modern biologics facilities are expected to span a wide bioreactor capacity range to de-risk scale transitions and maintain regulatory continuity from clinical through commercial supply. FDA’s ...
- Alva10 joins DXRX global network to enable critical piece of end-to-end solution for developing and commercializing precision medicine diagnostics - Partnership will improve test coverage and ...
The Helical virtual AI lab for pharma, an application layer that turns biological foundation models into decision-ready, ...
As the ages for marriage and childbirth rise, pregnancy is moving into the "planning zone." More couples are choosing the optimal time after considering health, finances, and careers. Reflecting this ...
Bioreactor portfolios of 1,000–15,000 L (including 5,000 and 10,000 L steps) are positioned to de-risk scale transitions while preserving comparability and regulatory rigor. FDA’s Emerging Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results